- New
-
Topics
- All Categories
- Metaphysics and Epistemology
- Value Theory
- Science, Logic, and Mathematics
- Science, Logic, and Mathematics
- Logic and Philosophy of Logic
- Philosophy of Biology
- Philosophy of Cognitive Science
- Philosophy of Computing and Information
- Philosophy of Mathematics
- Philosophy of Physical Science
- Philosophy of Social Science
- Philosophy of Probability
- General Philosophy of Science
- Philosophy of Science, Misc
- History of Western Philosophy
- Philosophical Traditions
- Philosophy, Misc
- Other Academic Areas
- Journals
- Submit material
- More
Is there a morally right price for anti-retroviral drugs in the developing world?
Business Ethics, the Environment and Responsibility 15 (1):29–43 (2005)
Abstract
This article has no associated abstract. (fix it)My notes
Similar books and articles
Is there a morally right price for anti‐retroviral drugs in the developing world?Paul Baines Ross Brennan - 2006 - Business Ethics, the Environment and Responsibility 15 (1):29-43.
Should patents for antiretrovirals be waived in the developing world? Annual varsity medical debate - London, 21 January 2011.Fenella Corrick, Robert Watson & Sanjay Budhdeo - 2011 - Philosophy, Ethics, and Humanities in Medicine 6:1-6.
MSI deliberations and context: The influence of Southeast Asian business systems on member justifications and approaches to anti-corruption.Luisa Murphy - 2021 - Business Ethics, the Environment and Responsibility 30 (4):25-43.
Testing drugs on animals: A test case for socially responsible investment.Robert Taylor - 2005 - Business Ethics, the Environment and Responsibility 14 (2):164–175.
Patent rights or patent wrongs? The case of patent rights on AIDS drugs.Paul Davey Samantha Byrne - 2006 - Business Ethics, the Environment and Responsibility 15 (3):299-305.
Patent rights or patent wrongs? The case of patent rights on AIDS drugs.Samantha Byrne, Paul Davey, Kirsti McFarlane, John O'Brien & Craig Templeton - 2006 - Business Ethics, the Environment and Responsibility 15 (3):299–305.
Who has responsibility for access to essential medical drugs in the developing world?Amitava Banerjee - 2006 - Ethics and Economics 4 (2).
Analytics
Added to PP
2009-01-28
Downloads
50 (#431,538)
6 months
6 (#825,551)
2009-01-28
Downloads
50 (#431,538)
6 months
6 (#825,551)
Historical graph of downloads
Citations of this work
Paying a high price for low costs: why there should be no legal constraints on the profits that can be made on drugs for tropical diseases.J. Sonderholm - 2009 - Journal of Medical Ethics 35 (5):315-319.
Are intellectual property rights compatible with Rawlsian principles of justice?Darryl J. Murphy - 2012 - Ethics and Information Technology 14 (2):109-121.
Ethical Analysis on the Application of Neurotechnology for Human Augmentation in Physicians and Surgeons.Soaad Hossain & Syed Ishtiaque Ahmed - 2021 - In Kohei Arai, Supriya Kapoor & Rahul Bhatia (eds.), Proceedings of the Future Technologies Conference (FTC) 2020. pp. 78-99.
References found in this work
A Theory of Justice.John Rawls - 1971 - Oxford,: Harvard University Press. Edited by Steven M. Cahn.
Utilitarianism: For and Against.J. J. C. Smart & Bernard Williams - 1973 - Cambridge: Cambridge University Press. Edited by Bernard Williams.
Virtue theory as a dynamic theory of business.Surendra Arjoon - 2000 - Journal of Business Ethics 28 (2):159 - 178.
PhilPapers logo by Andrea Andrews and Meghan Driscoll.
This site uses cookies and Google Analytics (see our terms & conditions for details regarding the privacy implications). Use of this site is subject to terms & conditions.
All rights reserved by The PhilPapers Foundation
Server: philpapers-web-667477cd97-2pm92 dc2